FreeStyle Libre system significantly reduces blood sugar and HbA1c: Study
Abbott's FreeStyle® Libre 3 System Receives CE Mark - Features World's Smallest, Thinnest Sensor with Best-in-Class Performance at the Same Low Cost for People with Diabetes
Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies | SpringerLink
HbA1c may not correlate with CGM metrics for some adults with type 2 diabetes
Large discrepancy between estimated A1c on Libreview vs Libre Link App | Diabetes Forum • The Global Diabetes Community
HBA1C and FreeStyle Libre | Diabetes Care | Newsroom
Study says Abbott FreeStyle Libre reduces rate of hospitalization
Real-World Data | Healthcare Professionals | Abbott
Does retrospective continuous glucose monitoring improve HbA1c among adults with type 2 diabetes? – ACBRD
Improving HbA1c Control in Type 1 or Type 2 Diabetes Using Flash Glucose Monitoring: A Retrospective Observational Analysis in Two German Centres | SpringerLink
Proven clinical outcomes for insulin users - FreeStyle Libre
New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life - Oct 6, 2022
FreeStyle Libre reduces type 2 diabetes HbA1c levels - The Diabetes Times
Abbott's FreeStyle® Libre 2 iCGM Cleared in U.S. for Adults and Children with Diabetes, Achieving Highest Level of Accuracy and Performance Standards - Jun 15, 2020
BJD
Reductions in HbA1c with Flash Glucose Monitoring Are Sustained for up to 24 Months: A Meta-Analysis of 75 Real-World Observational Studies | SpringerLink
Why is glucose monitoring important - FreeStyle Libre | Abbott
Abbott, Medtronic go head-to-head at ADA conference - Page 2 of 9 - Medical Design and Outsourcing